These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 401419)

  • 1. Vesical defense: further evidence for a charge-related mucosal anti-adherence mechanism.
    Shrom SH; Parsons CL; Mulholland SG
    Surg Forum; 1978; 29():632-3. PubMed ID: 401419
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder defense mechanism.
    Mulholland SG; Parsons CL; Shrom SH; Murphy JJ
    Trans Am Assoc Genitourin Surg; 1976; 68():83-6. PubMed ID: 801214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The primary antibacterial defense mechanism of the bladder.
    Parsons CL; Greenspan C; Mulholland SG
    Invest Urol; 1975 Jul; 13(1):72-8. PubMed ID: 1095522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect.
    Parsons CL; Shrom SH; Hanno PM; Mulholland SG
    Invest Urol; 1978 Nov; 16(3):196-200. PubMed ID: 30735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bacterial metabolic state on vesical mucosal adherence.
    Shrom SH; Parsons CL; Fritz RW; Mulholland SG
    Invest Urol; 1980 Jul; 18(1):77-9. PubMed ID: 6997226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesical defense: assessment of adsorption potential with live, dead, and metabolically inhibited Escherichia coli and 99mTC-labeled sulfur colloid particles.
    Shrom SH; Parsons CL; Alavi A; Mulholland SG
    Surg Forum; 1977; 28():565-7. PubMed ID: 364743
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of antiadherence activity of bladder extracts from interstitial cystitis patients with recurrent urinary tract infections.
    Ruggieri MR; Steinhardt GF; Hanno PM
    Semin Urol; 1991 May; 9(2):136-42. PubMed ID: 1853011
    [No Abstract]   [Full Text] [Related]  

  • 8. Bladder surface mucin. Its antibacterial effect against various bacterial species.
    Parsons CL; Mulholland SG
    Am J Pathol; 1978 Nov; 93(2):423-32. PubMed ID: 362941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
    Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
    Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rabbit vesical mucosa on bacterial growth.
    Mulholland SG; Foster EA; Paquin AJ; Gillenwater JY
    Invest Urol; 1969 May; 6(6):593-604. PubMed ID: 4890224
    [No Abstract]   [Full Text] [Related]  

  • 11. Bladder defense mechanisms against urinary tract infections.
    Schaeffer AJ
    Semin Urol; 1983 May; 1(2):106-13. PubMed ID: 6382529
    [No Abstract]   [Full Text] [Related]  

  • 12. Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance. Consequences for anti-adhesion therapy.
    Connell H; Agace W; Hedlund M; Klemm P; Shembri M; Svanborg C
    Adv Exp Med Biol; 1996; 408():73-80. PubMed ID: 8895779
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of surface mucin in primary antibacterial defense of bladder.
    Parsons CL; Greenspan C; Moore SW; Mulholland SG
    Urology; 1977 Jan; 9(1):48-52. PubMed ID: 831354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of the bladder mucosa.
    Schlager TA; Lohr JA; Hendley JO
    Urol Res; 1993; 21(5):313-7. PubMed ID: 8279086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of soluble virulence factor by Escherichia coli.
    Mostafavi M; Stein PC; Parsons CL
    J Urol; 1995 May; 153(5):1441-3. PubMed ID: 7714961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
    Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
    J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against urinary tract infections.
    Uehling DT; Jensen J; Balish E
    J Urol (Paris); 1985; 91(1):23-6. PubMed ID: 3900224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Criteria of bacterial count in urine. 3. The influence of antibacterial factor in the rabbit bladder on the growth of E. coli and Staphylococcus aureus in urine].
    Breunung M; Breunung MM
    Zentralbl Bakteriol Orig A; 1971 Nov; 218(3):290-300. PubMed ID: 4400265
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms.
    Parsons CL
    Urol Clin North Am; 1986 Nov; 13(4):563-8. PubMed ID: 2877517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.